RCC2P2

Across TCGA pan-cancer cohorts, RCC2P2 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RCC2P2 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RCC2P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RCC2P2 expression acts as an unfavorable survival marker.

LUAD, KIRC, and BLCA are the cancer types where RCC2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.223	0.749	.013	54	view →
KIRC	OS	Tertile	All	0.668	0.823	<.001	45	view →
BLCA	DFS	Tertile	All	0.224	0.522	.034	36	view →
COAD	OS	Tertile	II,III,IV	0.116	0.643	.044	18	view →
CESC	OS	Tertile	All	0.626	0.874	.041	18	view →
SKCM	OS	Tertile	III,IV	0.606	0.821	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RCC2P2–LUAD (OS)

Open the LUAD breakdown →